There is a large cohort of data implicating the BMP pathway in the etiology of PAH as heterozygous mutations within the gene encoding bone morphogenetic protein type II receptor (BMPR2) have been found in ~70 % of FPAH [3, 4] and ~26 % of IPAH cases [6]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.